Literature DB >> 19540599

Volumetric MRI study of the insular cortex in individuals with current and past major depression.

Tsutomu Takahashi1, Murat Yücel, Valentina Lorenzetti, Ryoichiro Tanino, Sarah Whittle, Michio Suzuki, Mark Walterfang, Christos Pantelis, Nicholas B Allen.   

Abstract

BACKGROUND: Functional neuroimaging studies have implicated the insular cortex in emotional processing, including the evaluation of one's own emotion, as well as in the neurobiology of major depressive disorder (MDD). Nevertheless, it remains largely unknown whether MDD patients exhibit morphologic changes of the insular cortex, and whether such changes reflect state or trait markers of the disorder.
METHODS: We delineated the anterior and posterior insular cortices using magnetic resonance imaging in 29 currently depressed patients (mean age=32.5 years, 7 males), 27 remitted depressed patients (mean age=35.1 years, 9 males), and 33 age- and gender-matched healthy control subjects (mean age=34.0 years, 12 males).
RESULTS: Both current and remitted MDD patients showed significant volume reduction of the left anterior insular cortex as compared with healthy controls, but there was no group difference in the posterior insular cortex volume. Insular volumes did not correlate with the severity of depressive symptoms. Furthermore, the presence of melancholia and co-morbidity with anxiety disorders did not affect insular cortex volumes. LIMITATIONS: Although there was no difference in the insular cortex volume between medicated and unmedicated patients, a comprehensive investigation of medication effects was not possible, as complete data (e.g., dose, duration) were not available.
CONCLUSIONS: These findings suggest that the morphologic abnormality of the anterior insular cortex, which plays a major role in introspection and emotional control, may be a trait-related marker of vulnerability to major depression, supporting the notion that MDD involves pathological alterations of limbic and related cortical structures. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19540599     DOI: 10.1016/j.jad.2009.06.003

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  44 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Anterior insula volume and guilt: neurobehavioral markers of recurrence after early childhood major depressive disorder.

Authors:  Andy C Belden; Deanna M Barch; Timothy J Oakberg; Laura M April; Michael P Harms; Kelly N Botteron; Joan L Luby
Journal:  JAMA Psychiatry       Date:  2015-01       Impact factor: 21.596

3.  Impaired interhemispheric connectivity in medication-naive patients with major depressive disorder.

Authors:  Ke Xu; Wenyan Jiang; Ling Ren; Xuan Ouyang; Yifeng Jiang; Feng Wu; Lingtao Kong; Fay Womer; Zhening Liu; Hilary P Blumberg; Yanqing Tang; Fei Wang
Journal:  J Psychiatry Neurosci       Date:  2013-01       Impact factor: 6.186

Review 4.  Causes of death among persons who survive an acute ischemic stroke.

Authors:  Shuai Zhang; Wen-Bin He; Nai-Hong Chen
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

5.  Lifetime major depression and grey-matter volume

Authors:  Marie-Laure Ancelin; Isabelle Carrière; Sylvaine Artero; Jerome Maller; Chantal Meslin; Karen Ritchie; Joanne Ryan; Isabelle Chaudieu
Journal:  J Psychiatry Neurosci       Date:  2019-01-01       Impact factor: 6.186

6.  Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.

Authors:  Elizabeth A Bartlett; Christine DeLorenzo; Priya Sharma; Jie Yang; Mengru Zhang; Eva Petkova; Myrna Weissman; Patrick J McGrath; Maurizio Fava; R Todd Ogden; Benji T Kurian; Ashley Malchow; Crystal M Cooper; Joseph M Trombello; Melvin McInnis; Phillip Adams; Maria A Oquendo; Diego A Pizzagalli; Madhukar Trivedi; Ramin V Parsey
Journal:  Neuropsychopharmacology       Date:  2018-06-19       Impact factor: 7.853

Review 7.  The Insula: An Underestimated Brain Area in Clinical Neuroscience, Psychiatry, and Neurology.

Authors:  Ho Namkung; Sun-Hong Kim; Akira Sawa
Journal:  Trends Neurosci       Date:  2017-03-15       Impact factor: 13.837

8.  Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.

Authors:  Oliver G Bosch; Fabrizio Esposito; Michael M Havranek; Dario Dornbierer; Robin von Rotz; Philipp Staempfli; Boris B Quednow; Erich Seifritz
Journal:  Neuropsychopharmacology       Date:  2017-05-31       Impact factor: 7.853

Review 9.  Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.

Authors:  Geraldo F Busatto
Journal:  Schizophr Bull       Date:  2013-04-24       Impact factor: 9.306

10.  Neuroimaging in psychiatry: from bench to bedside.

Authors:  David E J Linden; Andreas J Fallgatter
Journal:  Front Hum Neurosci       Date:  2009-12-23       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.